Menu Contents

Governance

You can check reports such as information on stockholders of Boryung Pharmaceutical.

  • Company overview

    You can see companyrelated status.

    Company overview

    Company overview
    Name Boryung Pharmaceutical CEO (present) An Jae-hyeon, Lee Sam-su
    Date of establishment 1963.11.11 Listing date 1988.10.24
    Representative industry Manufacturing Capital 23,810,000,000
    Settlement Term December Total capital KRW 648 billion (As of settlement term)
    Address of head office Boryung Building, 136 Changgyeonggung-ro, Jongno-gu, Seoul Telephone 708-8000

    Dividend status for past 5 years

    Written based on settlement term of Korean International Financial Reporting Standards(K-IFRS)

    Dividend status for past 5 years
    Division Types of stock The 57th The 56th The 55th The 54th The 53th
    Face value per stock (KRW) 500
    500
    500
    2,500
    2,500
    Face value per stock (KRW) 27,048
    32,222
    20,306
    56,478
    -
    (Separate) Net profit during the term (KRW 1 million) 26,860
    34,348
    22,902
    55,352
    5,614
    (Settlement Term)Net ) Earning per stock (KRW) 558
    744
    544
    1,334
    -
    Total cash dividend (KRW 1 million) 4,511
    4,204
    2,522
    6,800
    1,619
    Total stock dividend (KRW 1 million) -
    -
    -
    -
    -
    (Settlement Term) Dividend payout ratio(%) 16.68 13.05 12.42 12.04 28.83
    Dividend earring rate (%) Common stock 0.5 0.7 0.6 1.9 0.4
    Preferred stock - - - - -
    Stock dividend earning rate (%) Common stock - - - - -
    Preferred stock - - - - -
    Dividend per stock (KRW) Common stock 100 100 60 800 200
    Preferred stock - - - - -
    Stock dividend per stock (Stock) Common stock - - - - -
    Preferred stock - - - - -

    Status of Stock Distribution

    The largest shareholder and status of stock ownership with special relations

    As of December 31, 2020

    The largest shareholder and status of stock ownership with special relations
    Name Relations Type of stock Number of stock owned and ownership percentage
    Beginning of term End of term
    Number of stock Ownership percentage Number of stock Ownership percentage
    Boryung Holdings Co., Ltd. Oneself Common stock 14,918,405 33.75 18,542,523 38.94
    Kim Seung-ho Executive of the affiliates Common stock 0 0 296,692 0.62
    Kim Eun-seon Executive Common stock 5,412,040 12.24 5,412,040 11.37
    Kim Jeong-gyun Executive of the affiliates Common stock 619,520 1.4 619,520 1.3
    Medience Co., Ltd. The affiliates Common stock 2,305,502 5.22 2,305,502 4.84
    Boryung Jungbo Foundation Foundation Common stock 60,715 0.14 60,715 0.13
    Total Common stock 23,316,182 52.75 27,236,992 57.2

    Minority Shareholder

    As of December 31, 2020

    Minority Shareholder
    Division Number of shareholders Percentage Number of stock Percentage Remark
    Minority Shareholder 22,578 99.88% 16,136,070 33.89% -
  • Matters on stock

    You can check matters on stock.

    Details on stock issue

    As of December 31, 2020

    Details on stock issue
    Division Total number of stock issued Total face value Remark
    Common stock 47,620,000 stocks KRW 23,810,000,000
    Preferred stock - -
    Total 47,620,000 stocks KRW 23,810,000,000

    Details on stock issue

    As of December 31, 2020

    주식발행내역
    Division Total number of stock issued Total face value Remark
    Common stock 47,620,000 stocks KRW 23,810,000,000
    Preferred stock - -
    Total 47,620,000 stocks KRW 23,810,000,000

    Status of treasury stock distribution

    As of December 31, 2020

    Status of treasury stock distribution
    Division Number of stock Remark
    Common stock 2,509,033 stocks
    Preferred stock -
    Total 2,509,033 stocks

    ※ Acquisition of treasury stock by trust contract

    Status of treasury stock distribution

    As of December 31, 2020

    Status of treasury stock distribution
    Division Number of stock Remark
    Common stock 2,509,033 stocks
    Preferred stock -
    Total 2,509,033 stocks

    ※ Acquisition of treasury stock by trust contract

  • Matters on Board ofDirector

    You can check the information on BOD (Board of Director) status

    Status of BOD composition (Registered directors)

    As of March 2020

    Status of BOD composition (Registered directors)
    Division Position (full time or not) Name Date of appointment Term Remit Liability insurance
    Full-time director CEO An Jae-hyeong 2020.03.24 3 years Overall management Subscribed
    CEO Lee Sam-su 2019.03.25 3 years Overall management Subscribed
    Internal director Kim Eun-seon 2018.03.27 3 years Overall management Subscribed
    Internal director Jang Du-hyeon 2019.03.25 3 years Overall management Subscribed
    Part-time director Outside director Park Yu-sik 2019.03.25 3 years Outside director Subscribed
    Outside director Cheon In-gu 2019.03.25 3 years Outside director Subscribed

    * Presidential statement: An Jae-hyeon / Total number of directors: 6
    * Status of registered directors after having the 45th general meeting of shareholder (2020.03.24)

    Status of BOD Operation (2020)

    Status of BOD Operation (2020)
    Times Date Main agenda Pass Internal directors Outside directors
    An Jae-hyeon
    (Attendance Rate: 100%)
    Lee Sam-su
    (Attendance Rate: 100%)
    Kim Eun-seon
    (Attendance Rate: 100%)
    Kim Eun-seon
    (Attendance Rate: 100%)
    Park Yun-sik
    (Attendance Rate: 100%)
    Cheon In-gu
    (Attendance Rate: 100%)
    Agree/
    disagree
    Agree/
    disagree
    Agree/
    disagree
    Agree/
    disagree
    Agree/
    disagree
    Agree/
    disagree
    1 2020.01.02 No. 1 agenda: Extension of trust contract for acquiring treasury stock Pass Agree Agree Agree Agree Agree Agree
    2 2020.02.27 No. 1 agenda: Holding the 55th general meeting of shareholder Pass Agree Agree Agree Agree Agree Agree
    No. 2 agenda: Recommendation of director candidates Pass Agree Agree Agree Agree Agree Agree
    No. 3 agenda: Decision on agenda for the 56th general meeting of shareholder Pass Agree Agree Agree Agree Agree Agree
    No. 4 agenda: Revision of internal accounting management regulations Pass Agree Agree Agree Agree Agree Agree
    No. 5 agenda: Approval of transaction with American Corporation of Holdings (Hayan Health Networks) Pass Agree Agree Agree Agree Agree Agree
    No. 6 agenda: Extension of expiration of owing to bank Pass Agree Agree Agree Agree Agree Agree
    No. 7 agenda: Extension of trust contract for acquiring treasury stock Pass Agree Agree Agree Agree Agree Agree
    3 2020.03.20 No. 1 agenda: Appointment of CEO Pass Agree Agree Agree Agree Agree Agree
    4 2020.04.20 No. 1 agenda: Acquisition of brand Pass Agree Agree Agree Agree Agree Agree
    5 2020.05.11 No. 1 agenda: Decision on capital increase by issuing new stocks by third-party Pass Agree Agree Agree Agree Agree Agree
    6 2020.06.04 No.1 agenda: Issuance of public bond without guarantee Pass Agree Agree Agree Agree Agree Agree
    7 2020.06.30 No. 1 agenda: Incorporation of Boryung Consumer Health Care ad the affiliate Pass Agree Agree Agree Agree Agree Agree
    No.2 agenda: Incorporation of Hayan Health Networks as the affiliate Pass Agree Agree Agree Agree Agree Agree
    No. 3 agenda: Fund investment Pass Agree Agree Agree Agree Agree Agree
    8 2020.07.27 No. 1 agenda: Capital increase of BORYUNG HONGKONG Ltd Pass Agree Agree Agree Agree Agree Agree
    9 2020.09.28 No. 1 agenda: Extension of trust contract for acquiring treasury stock Pass Agree Agree Agree Agree Agree Agree
    10 2020.11.09 No. 1 agenda: Extension of trust contract for acquiring treasury stock Pass Agree Agree Agree Agree Agree Agree
    11 2020.11.30 No. 1 agenda: Report on management review of ISO37001 anti-bribery management system Pass Agree Agree Agree Agree Agree Agree
    12 2020.12.10 No. 1 agenda: Capital transfer of reserve fund (Capital increase without consideration) Pass Agree Agree Agree Agree Agree Agree
    No. 2 agenda: Change on person in charge of anti-bribery and compliance manager
  • Matters on Audit Organization

    You can check matters on audit organization

    Full time audit

    Full time audit
    Division Name Date of appointment Terms Liability insurance
    Full time audit Lee Jae-sul 2019.3.22 3 years Subscribed

    Outside audit

    Outside audit
    Corporate name Date of appointment Contract terms Recent audit opinion
    Samil PricewaterhouseCoopers 2020.02.13 2021.01.01 ~ 2023.12.31 Appropriate
  • Difference Betweenthe Best Standard of Corporate Governance

    You can check the information on difference from the best standard of corporate governance.

    Difference between the Ideal Standard of Corporate Governance

    Difference between the ideal standard of corporate governance
    Recommendation of best standard Adoption by Boryung Pharmaceutical Remark
    Introduction of corporate governance charter X  
    Voting in writing X  
    Concentrated vote system X  
    Concentrated vote system X  
    Announcement of activities of BOD O  
    Composition of director recommendation committee X  
    Composition of audio committee X  
    Enactment and announcement of corporate ethical regulations O  
    Announcement of differences from best standard O Posted on internet webpage
    Subscription of indemnity insurance of directors at the company’s expenses O Subscription of indemnity insurance of executives (Renewal every year)
    Accuracy certification on business report O Subscription of indemnity insurance of executives (Renewal every year)
TOP